Literature DB >> 6254597

Pharmacological differentiation of presynaptic inhibitory alpha-adrenoceptors and opiate receptors in the cat nictitating membrane.

M L Dubocovich, S Z Langer.   

Abstract

1 The action of morphine, naturally occurring and synthetic opiate peptides on [3H]-noradrenaline release induced by nerve stimulation was studied in the isolated nerve muscle preparation of the cat nictitating membrane under experimental conditions in which the alpha-presynaptic receptors were blocked by phentolamine 1 microM. 2 Morphine and the naturally occurring peptides: [Met5]-enkephalin, [Leu5]-enkephalin and beta-endorphin reduced 3H-transmitter overflow and responses to nerve stimulation from the cat nictitating membrane, effects which were completely antagonized by naloxone 0.3 microM. The relative order of potency for the inhibition of the stimulation-induced 3H-transmitter overflow at the level of the IC50 (microM) was as follows: [Met5]-enkephalin (0.020 microM) greater than or equal to [Leu5]-enkephalin (0.036 microM) > morphine (0.3 microM) > beta-endorphin (1 microM). 3 The synthetic opiate pentapeptides: BW 180 C (Tyr-D-Ala-Gly-Phe-D-Leu), and BW834 C (Tyr-D-Ala-Gly-pClPhe-DLeu), which are resistant to enzymatic degradation were more potent than the enkephalins in reducing the stimulation-evoked transmitter overflow from the cat nictitating membrane. On the other hand, the tetrapeptide BW832 C, which lacks the D-leucine terminal of BW180 C l was less potent than the enkephalins in inhibiting neurotransmission. 4 In the presence of phenoxybenzamine 1 microM, 3H-transmitter overflow was increased 8 fold and the inhibition of neurotransmission by methionine-enkephalin was not affected. Exposure to phenoxybenzamine 10 microM increased [3H]-noradrenaline overflow 15 fold and antagonized the effects of methionine enkephalin on transmitter release. 5 In the cat nictitating membrane the inhibitory presynaptic opiate receptors are different from the presynaptic alpha-autoreceptors which regulate the release of noradrenaline elicited by nerve depolarization through a negative feed-back mechanism.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6254597      PMCID: PMC2044347          DOI: 10.1111/j.1476-5381.1980.tb08714.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  40 in total

1.  Inhibition by dopamine of 3H-noradrenaline release elicited by nerve stimulation in the isolated cat's nictitating membrane.

Authors:  M A Enero; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

2.  Alpha sympathomimetic inhibition of adrenergic and cholinergic transmission in the rabbit heart.

Authors:  K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

3.  The variation of noradrenaline output with frequency of nerve stimulation and the effect of morphine on the cat nictitating membrane and on the guinea-pig myenteric plexus.

Authors:  G Henderson; J Hughes; J W Thompson
Journal:  Br J Pharmacol       Date:  1972-11       Impact factor: 8.739

4.  Effect of a potent synthetic opioid pentapeptide in some anti-nociceptive and behavioural tests in mice and rats [proceedings].

Authors:  M G Baxter; D Goff; A A Miller; I A Saunders
Journal:  Br J Pharmacol       Date:  1977-03       Impact factor: 8.739

5.  Differences in the inhibitory effects of normorphine and opioid peptides on the responses of the vasa deferentia of two strains of mice.

Authors:  A A Waterfield; J A Lord; J Hughes; H W Kosterlitz
Journal:  Eur J Pharmacol       Date:  1978-01-15       Impact factor: 4.432

6.  Morphine and beta-endorphin inhibit release of noradrenaline from cerebral cortex but not of dopamine from rat striatum.

Authors:  S Arbilla; S Z Langer
Journal:  Nature       Date:  1978-02-09       Impact factor: 49.962

7.  Influence of morphine and naloxone on the release of noradrenaline from rat brain cortex slices.

Authors:  H Montel; K Starke; F Weber
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

8.  Enkephalin: a potential modulator of noradrenaline release in rat brain.

Authors:  H D Taube; E Borowski; T Endo; K Starke
Journal:  Eur J Pharmacol       Date:  1976-08       Impact factor: 4.432

9.  Inhibition of dopamine-stimulated adenylate cyclase activity by phenoxybenzamine.

Authors:  K G Walton; P Liepmann; R J Baldessarini
Journal:  Eur J Pharmacol       Date:  1978-11-15       Impact factor: 4.432

10.  Isolation of a novel endogenous opiate analgesic from human blood.

Authors:  C B Pert; A Pert; J F Tallman
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

View more
  4 in total

1.  Presynaptic alpha 2-adrenoceptor, opioid kappa-receptor and adenosine A1-receptor interactions on noradrenaline release in rabbit brain cortex.

Authors:  N Limberger; L Späth; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-07       Impact factor: 3.000

2.  Enkephalinergic inhibition in parasympathetic ganglia of the urinary bladder of the cat.

Authors:  W C de Groat; M Kawatani
Journal:  J Physiol       Date:  1989-06       Impact factor: 5.182

3.  Alpha 2-adrenoceptors inhibit the cholera-toxin-induced intestinal fluid accumulation.

Authors:  T Nakaki; T Nakadate; S Yamamoto; R Kato
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

4.  Interaction between presynaptic facilitatory angiotensin II receptors and inhibitory muscarinic cholinoceptors on 3H-noradrenaline release in the rabbit heart.

Authors:  J A García-Sevilla; M L Dubocovich; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-07       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.